TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 6 | 15 | 28 | 27 | 29 | 124 | 38 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/18 08:52 | 3/8/18 | SCYX | Scynexis Inc | Health | Drug | Pharmaceutical Preparations | Hastings David C | NJ | D | P.d | 20 | 1.69 | 0 | 12 | 59 | 32 | D | ||||||||||||||||
6/22/17 08:58 | 6/21/17 | SCYX | Scynexis Inc | Health | Drug | Pharmaceutical Preparations | Hastings David C | NJ | D | P | 35 | 1.75 | 0 | 20 | New | 20 | D | ||||||||||||||||
7/6/10 07:51 | 7/1/10 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | P | 20 | 10.24 | 21 | 2 | 31 | 9 | D | 44 | 218 | 18 | -27 | -14 | -18 | -10 | -5 | 0 | 9 | 25 | 47 | 54 | 80 |
11/21/08 08:02 | 11/20/08 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | P | 9 | 2.36 | 4 | 4 | 160 | 7 | D | -53 | -69 | -75 | -75 | -44 | -40 | -40 | -32 | 13 | 34 | 41 | 8 | 18 | 203 |
4/5/06 08:25 | 4/4/06 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Hastings David C | DE | O | CFO | P | 9 | 3.60 | 6 | 3 | New | 3 | 6 | 3 | 17 | 27 | 15 | 89 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |